239 related articles for article (PubMed ID: 11100383)
21. [Development of scirrhous cancer of the stomach; a speculation from clinical materials obtained].
Yoshida S; Saito D
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-2):1241-8. PubMed ID: 2837984
[TBL] [Abstract][Full Text] [Related]
22. Results of immunochemo-surgery for gastric carcinoma.
Kim JP; Yu HJ; Lee JH
Hepatogastroenterology; 2001; 48(41):1227-30. PubMed ID: 11677936
[TBL] [Abstract][Full Text] [Related]
23. Recurrence in early gastric cancer--presence of micrometastasis in lymph node of node negative early gastric cancer patient with recurrence.
Saito H; Osaki T; Murakami D; Sakamoto T; Kanaji S; Ohro S; Tatebe S; Tsujitani S; Ikeguchi M
Hepatogastroenterology; 2007 Mar; 54(74):620-4. PubMed ID: 17523336
[TBL] [Abstract][Full Text] [Related]
24. Clinicopathological study of mucinous gastric carcinoma.
Shibuya H; Nishida R; Koide S; Kurokawa J; Okita K
Ann Chir Gynaecol; 2000; 89(4):273-6. PubMed ID: 11204957
[TBL] [Abstract][Full Text] [Related]
25. [Important prognostic factors in surgically treated gastric cancer patients].
Hiratsuka M; Iwanaga T; Furukawa H; Yasuda T; Nakano H; Nakamori S; Ohigashi H; Kameyama M; Sasaki Y; Kabuto T
Gan To Kagaku Ryoho; 1995 Apr; 22(5):703-8. PubMed ID: 7717727
[TBL] [Abstract][Full Text] [Related]
26. [Surgical results of scirrhous carcinoma of the stomach].
Kito T; Yamamura Y
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-2):1256-61. PubMed ID: 2837985
[TBL] [Abstract][Full Text] [Related]
27. Clinicopathologic prognostic factors in patients with Borrmann type 4 gastric cancer: univariate and multivariate analyses.
Yokota T; Kunii Y; Saito T; Teshima S; Narushima Y; Yamada Y; Iwamoto K; Kagami M; Takahashi M; Kikuchi S; Yamauchi H
Ups J Med Sci; 2000; 105(3):227-34. PubMed ID: 11261608
[TBL] [Abstract][Full Text] [Related]
28. Survival predictors in patients with node-negative gastric carcinoma.
Lee CC; Wu CW; Lo SS; Chen JH; Li AF; Hsieh MC; Shen KH; Lui WY
J Gastroenterol Hepatol; 2007 Jul; 22(7):1014-8. PubMed ID: 17608847
[TBL] [Abstract][Full Text] [Related]
29. Long-term survival and prognostic factors in patients with metastatic gastric cancers treated with chemotherapy in the Japan Clinical Oncology Group (JCOG) study.
Yoshida M; Ohtsu A; Boku N; Miyata Y; Shirao K; Shimada Y; Hyodo I; Koizumi W; Kurihara M; Yoshida S; Yamamoto S
Jpn J Clin Oncol; 2004 Nov; 34(11):654-9. PubMed ID: 15613554
[TBL] [Abstract][Full Text] [Related]
30. Gastric cancer: correlation between clinicopathological factors and survival of patients (III).
Lazăr D; Tăban S; Sporea I; Dema A; Cornianu M; Lazăr E; Goldiş A; Vernic C
Rom J Morphol Embryol; 2009; 50(3):369-79. PubMed ID: 19690762
[TBL] [Abstract][Full Text] [Related]
31. Gastric cancer with invasion limited to the muscularis propria.
Yokota T; Kunii Y; Teshima S; Yamada Y; Saito T; Kikuchi S; Yamauchi H
Int Surg; 1999; 84(1):7-12. PubMed ID: 10421010
[TBL] [Abstract][Full Text] [Related]
32. [Analysis of long-term results of radical gastrectomy combining splenectomy for gastric cancer].
Han FH; Zhan WH; Li YM; He YL; Peng JS; Ma JP; Wang Z; Chen ZX; Zheng ZQ; Wang JP; Huang YH; Dong WG
Zhonghua Wai Ke Za Zhi; 2005 Sep; 43(17):1114-7. PubMed ID: 16194307
[TBL] [Abstract][Full Text] [Related]
33. [Peritoneal dissemination of scirrhous type 4 gastric cancers].
Koufuji K; Aoyagi K; Yano S; Murakami N; Miyagi M; Imaizumi T; Shirouzu K
Gan To Kagaku Ryoho; 2005 Oct; 32(10):1384-8. PubMed ID: 16227734
[TBL] [Abstract][Full Text] [Related]
34. Paraaortic lymph node dissection for gastric cancer in 244 consecutive cases.
Kosaka T; Usami K; Ueshige N; Hasegawa T; Yoshitani S; Sugaya J; Nakano Y; Takashima S
Hepatogastroenterology; 2006; 53(70):629-33. PubMed ID: 16995477
[TBL] [Abstract][Full Text] [Related]
35. Prognostic influence of sub-stages according to pTNM categories in patients with stage IV gastric cancer.
Li C; Yan M; Chen J; Xiang M; Zhu ZG; Lin YZ
J Surg Oncol; 2009 May; 99(6):324-8. PubMed ID: 19204941
[TBL] [Abstract][Full Text] [Related]
36. Limited effectiveness of extended lymph-node dissection for node-negative patients with proximal gastric cancer.
Kikuchi S; Katada N; Sakuramoto S; Kobayashi N; Shimao H; Sakakibara Y; Sato K; Kakita A
Anticancer Res; 2001; 21(2B):1359-62. PubMed ID: 11396213
[TBL] [Abstract][Full Text] [Related]
37. [Surgical treatment and prognosis analysis for patients with gastric cancer infiltrating esophagus].
Han FH; Zhan WH; He YL; Li YM; Zheng ZQ; Peng JS; Cai SR; Ma JP
Zhonghua Wei Chang Wai Ke Za Zhi; 2005 May; 8(3):199-202. PubMed ID: 16167226
[TBL] [Abstract][Full Text] [Related]
38. Clinicopathological characteristics of signet ring cell carcinoma of the stomach.
Kim DY; Park YK; Joo JK; Ryu SY; Kim YJ; Kim SK; Lee JH
ANZ J Surg; 2004 Dec; 74(12):1060-4. PubMed ID: 15574148
[TBL] [Abstract][Full Text] [Related]
39. Indications for pancreaticosplenectomy in advanced gastric cancer.
Chikara K; Hiroshi S; Masato N; Hirotoshi A; Goro M; Hidetaka O
Hepatogastroenterology; 2001; 48(39):908-12. PubMed ID: 11462954
[TBL] [Abstract][Full Text] [Related]
40. Prognostic factors in patients with advanced gastric cancer treated by noncurative resection: a multivariate analysis.
Tsujitani S; Oka S; Suzuki K; Saito H; Kondo A; Ikeguchi M; Maeta M; Kaibara N
Hepatogastroenterology; 2001; 48(41):1504-8. PubMed ID: 11677996
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
